{
    "organizations": [],
    "uuid": "277f96f8a4bf000e6fe1cdf5e75b72049da0c6d7",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-immunovaccine-has-applied-to-list/brief-immunovaccine-has-applied-to-list-its-common-shares-on-nasdaq-idUSFWN1SA0S5",
    "ord_in_thread": 0,
    "title": "Immunovaccine Has Applied To List Its Common Shares On Nasdaq",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 3 (Reuters) - Immunovaccine Inc:\n* IMMUNOVACCINE INC. HAS APPLIED TO LIST ITS COMMON SHARES ON NASDAQ, ANNOUNCES REVERSE STOCK SPLIT\n* IMMUNOVACCINE INC - IMPLEMENTING A CONSOLIDATION OF ITS OUTSTANDING COMMON SHARES, AND CHANGING CORPORATION NAME TO IMV INC\n* IMMUNOVACCINE - SHARE CONSOLIDATION WILL BE DONE ON BASIS OF 1 NEW SHARE FOR EVERY 3.2 CURRENTLY OUTSTANDING SHARES\n* IMMUNOVACCINE - CURRENTLY ANTICIPATES COMMON SHARES WOULD BEGIN TRADING ON NASDAQ BEFORE END OF Q2 2018 Source text for Eikon:\nOur ",
    "published": "2018-05-03T19:12:00.000+03:00",
    "crawled": "2018-05-04T16:52:56.002+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "immunovaccine",
        "inc",
        "immunovaccine",
        "applied",
        "list",
        "common",
        "share",
        "nasdaq",
        "announces",
        "reverse",
        "stock",
        "split",
        "immunovaccine",
        "inc",
        "implementing",
        "consolidation",
        "outstanding",
        "common",
        "share",
        "changing",
        "corporation",
        "name",
        "imv",
        "inc",
        "immunovaccine",
        "share",
        "consolidation",
        "done",
        "basis",
        "new",
        "share",
        "every",
        "currently",
        "outstanding",
        "share",
        "immunovaccine",
        "currently",
        "anticipates",
        "common",
        "share",
        "would",
        "begin",
        "trading",
        "nasdaq",
        "end",
        "q2",
        "source",
        "text",
        "eikon"
    ]
}